Proton magnetic resonance spectroscopy of malformations of cortical development causing epilepsy

Epilepsy Research

Volumn 74, Issue 2-3, 2007, Pages 107-115

  Simister, Robert J ^a   McLean, Mary A ^a   Barker, Gareth J ^b   Duncan, John S ^a  

^a EPILEPSY SOCIETY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Gamma aminobutyric acid; Glutamate; Magnetic resonance spectroscopy; Malformations of cortical development; N Acetyl aspartate

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLINE; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; HOMOCARNOSINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN MALFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DEVELOPMENT MALFORMATION; EPILEPSY; FEMALE; HETEROTOPIA; HUMAN; MALE; MICROGYRIA; OCCIPITAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADOLESCENT; ADULT; ALGORITHMS; ANTICONVULSANTS; BRAIN CHEMISTRY; CEREBRAL CORTEX; EPILEPSY; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMINE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS;

EID: 34247553886     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2007.02.002     Document Type: Article

References (53)

1. Aasly J., Silfvenius H., Aas T.C., Sonnewald U., Olivecrona M., Juul R., and White L.R. Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy. Epilepsy Res. 35 (1999) 211-217
2. Baslow M.H. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem. Res. 28 (2003) 941-953
3. Ben Ari Y. Excitatory actions of gaba during development: the nature of the nurture. Nat. Rev. Neurosci. 3 (2002) 728-739
4. Ben Ari Y., and Holmes G.L. The multiple facets of gamma-aminobutyric acid dysfunction in epilepsy. Curr. Opin. Neurol. 18 (2005) 141-145
5. Benardete E.A., and Kriegstein A.R. Increased excitability and decreased sensitivity to GABA in an animal model of dysplastic cortex. Epilepsia 43 (2002) 970-982
6. Calcagnotto M.E., Paredes M.F., and Baraban S.C. Heterotopic neurons with altered inhibitory synaptic function in an animal model of malformation-associated epilepsy. J. Neurosci. 22 (2002) 7596-7605
7. Cendes F., Caramanos Z., Andermann F., Dubeau F., and Arnold D.L. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Ann. Neurol. 42 (1997) 737-746
8. Henry P.G., Dautry C., Hantraye P., and Bloch G. Brain GABA editing without macromolecule contamination. Magn. Reson. Med. 45 (2001) 517-520
9. Henry T.R., and Theodore W.H. Homocarnosine elevations: a cause or a sign of seizure control?. Neurology 56 (2001) 698-699
10. Jacobs K.M., Hwang B.J., and Prince D.A. Focal epileptogenesis in a rat model of polymicrogyria. J. Neurophysiol. 81 (1999) 159-173
11. Keltner J.R., Wald L.L., Frederick B.D., and Renshaw P.F. In vivo detection of GABA in human brain using a localized double-quantum filter technique. Magn. Reson. Med. 37 (1997) 366-371
12. 1H MR spectroscopy. Magn. Reson. Med. 48 (2002) 611-616
13. Kothare S.V., VanLandingham K., Armon C., Luther J.S., Friedman A., and Radtke R.A. Seizure onset from periventricular nodular heterotopias: depth-electrode study. Neurology 51 (1998) 1723-1727
14. 1H magnetic resonance spectroscopy. Magn. Reson. Med. 48 (2002) 949-958
15. Kullmann D.M., and Semyanov A. Glutamatergic modulation of GABAergic signaling among hippocampal interneurons: novel mechanisms regulating hippocampal excitability. Epilepsia 43 Suppl. 5 (2002) 174-178
16. Kuzniecky R., Hetherington H., Pan J., Hugg J., Palmer C., Gilliam F., Faught E., and Morawetz R. Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy. Neurology 48 (1997) 1018-1024
17. Kuzniecky R., Ho S., Pan J., Martin R., Gilliam F., Faught E., and Hetherington H. Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 58 (2002) 368-372
18. Li L.M., Cendes F., Bastos A.C., Andermann F., Dubeau F., and Arnold D.L. Neuronal metabolic dysfunction in patients with cortical developmental malformations: a proton magnetic resonance spectroscopic imaging study. Neurology 50 (1998) 755-759
19. Lynch J., Peeling J., Auty A., and Sutherland G.R. Nuclear magnetic resonance study of cerebrospinal fluid from patients with multiple sclerosis. Can. J. Neurol. Sci. 20 (1993) 194-198
20. Marsh L., Lim K.O., Sullivan E.V., Lane B., and Spielman D. Proton magnetic resonance spectroscopy of a gray matter heterotopia. Neurology 47 (1996) 1571-1574
21. Mattia D., Olivier A., and Avoli M. Seizure-like discharges recorded in human dysplastic neocortex maintained in vitro. Neurology 45 (1995) 1391-1395
22. McLean M.A., Busza A.L., Wald L.L., Simister R.J., Barker G.J., and Williams S.R. In vivo GABA+ measurement at 1.5 T using a PRESS-localized double quantum filter. Magn. Reson. Med. 48 (2002) 233-241
23. McLean M.A., Woermann F.G., Barker G.J., and Duncan J.S. Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter. Magn. Reson. Med. 44 (2000) 401-411
24. 1H-magnetic resonance spectroscopic imaging (MRSI) of the temporal lobes. Neuroimage 14 (2001) 501-509
25. Mescher M., Merkle H., Kirsch J., Garwood M., and Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 11 (1998) 266-272
26. Mueller S.G., Laxer K.D., Barakos J.A., Cashdollar N., Flenniken D.L., Vermathen P., Matson G.B., and Weiner M.W. Metabolic characteristics of cortical malformations causing epilepsy. J. Neurol. 252 (2005) 1082-1092
27. 1H NMR-spectroscopy: responder characteristics. Epilepsia 42 (2001) 29-40
28. Olsen R.W., and Avoli M. GABA and epileptogenesis. Epilepsia 38 (1997) 399-407
29. Palmini A., Gambardella A., Andermann F., Dubeau F., da Costa J.C., Olivier A., Tampieri D., Gloor P., Quesney F., and Andermann E. Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann. Neurol. 37 (1995) 476-487
30. Petroff O.A., Errante L.D., Rothman D.L., Kim J.H., and Spencer D.D. Glutamate-glutamine cycling in the epileptic human hippocampus. Epilepsia 43 (2002) 703-710
31. Petroff O.A., Hyder F., Collins T., Mattson R.H., and Rothman D.L. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures. Epilepsia 40 (1999) 958-964
32. Petroff O.A., Hyder F., Rothman D.L., and Mattson R.H. Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures. Neurology 56 (2001) 709-715
33. Petroff O.A., Mattson R.H., and Rothman D.L. Proton MRS: GABA and glutamate. Adv. Neurol. 83 (2000) 261-271
34. Petroff O.A., Pleban L.A., and Spencer D.D. Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. Magn. Reson. Imaging 13 (1995) 1197-1211
35. Petroff O.A., Rothman D.L., Behar K.L., Hyder F., and Mattson R.H. Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures. Seizure 8 (1999) 120-127
36. Petroff O.A., Rothman D.L., Behar K.L., and Mattson R.H. Low brain GABA level is associated with poor seizure control. Ann. Neurol. 40 (1996) 908-911
37. Pouwels P.J., and Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn. Reson. Med. 39 (1998) 53-60
38. Prince D.A., Jacobs K.M., Salin P.A., Hoffman S., and Parada I. Chronic focal neocortical epileptogenesis: does disinhibition play a role?. Can. J. Physiol. Pharmacol. 75 (1997) 500-507
39. Provencher S.W. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 14 (2001) 260-264
40. Redecker C., Luhmann H.J., Hagemann G., Fritschy J.M., and Witte O.W. Differential downregulation of GABAA receptor subunits in widespread brain regions in the freeze-lesion model of focal cortical malformations. J. Neurosci. 20 (2000) 5045-5053
41. Serles W., Li L.M., Antel S.B., Cendes F., Gotman J., Olivier A., Andermann F., Dubeau F., and Arnold D.L. Time course of postoperative recovery of N-acetyl-aspartate in temporal lobe epilepsy. Epilepsia 42 (2001) 190-197
42. Simister R.J., McLean M.A., Barker G.J., and Duncan J.S. A proton magnetic resonance spectroscopy study of metabolites in the occipital lobes in epilepsy. Epilepsia (2003)
43. Simister R.J., McLean M.A., Barker G.J., and Duncan J.S. Proton magnetic resonance spectroscopy reveals frontal lobe metabolite abnormalities in idiopathic generalised epilepsy. Neurology (2003)
44. Simister R.J., Woermann F.G., McLean M.A., Bartlett P.A., Barker G.J., and Duncan J.S. A short-echo-time proton magnetic resonance spectroscopic imaging study of temporal lobe epilepsy. Epilepsia 43 (2002) 1021-1031
45. Simone I.L., Federico F., Tortorella C., De Blasi R., Bellomo R., Lucivero V., Carrara D., Bellacosa A., Livrea P., and Carella A. Metabolic changes in neuronal migration disorders: evaluation by combined MRI and proton MR spectroscopy. Epilepsia 40 (1999) 872-879
46. Sisodiya S.M. Wiring, dysmorphogenesis and epilepsy: a hypothesis. Seizure 4 (1995) 169-185
47. Sisodiya S.M., Free S.L., Stevens J.M., Fish D.R., and Shorvon S.D. Widespread cerebral structural changes in patients with cortical dysgenesis and epilepsy. Brain 118 Pt 4 (1995) 1039-1050
48. Tasch E., Cendes F., Li L.M., Dubeau F., Andermann F., and Arnold D.L. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. Ann. Neurol. 45 (1999) 568-576
49. 1H NMR spectroscopy. Magn. Reson. Med. 50 (2003) 24-32
50. Urenjak J., Williams S.R., Gadian D.G., and Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem. 59 (1992) 55-61
51. Widjaja E., Griffiths P.D., and Wilkinson I.D. Proton MR spectroscopy of polymicrogyria and heterotopia. AJNR 24 (2003) 2077-2081
52. Woermann F.G., McLean M.A., Bartlett P.A., Barker G.J., and Duncan J.S. Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy. Brain 124 (2001) 427-436
53. 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann. Neurol. 45 (1999) 369-376